

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.81980122 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.39387136 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.11700262 |
| 4 | regulation of extracellular matrix disassembly (GO:0010715) | 5.08224828 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.87611495 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.82259096 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.81085991 |
| 8 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.70291853 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.50813859 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.34256972 |
| 11 | vocalization behavior (GO:0071625) | 4.31580240 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 4.24677304 |
| 13 | * glutamate secretion (GO:0014047) | 4.19086115 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.12628310 |
| 15 | glutamate receptor signaling pathway (GO:0007215) | 4.07617953 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.97423360 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.94598763 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 3.92061200 |
| 19 | protein localization to synapse (GO:0035418) | 3.79516259 |
| 20 | exploration behavior (GO:0035640) | 3.73256996 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.71835496 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.71449777 |
| 23 | sodium ion export (GO:0071436) | 3.70962075 |
| 24 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.69250591 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.62509534 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.60706890 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.60625032 |
| 28 | neuronal action potential propagation (GO:0019227) | 3.52937491 |
| 29 | * neurotransmitter secretion (GO:0007269) | 3.51440498 |
| 30 | proline transport (GO:0015824) | 3.48649957 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48474787 |
| 32 | detection of calcium ion (GO:0005513) | 3.47909942 |
| 33 | regulation of Rac protein signal transduction (GO:0035020) | 3.47786181 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 3.45480841 |
| 35 | cell adhesion mediated by integrin (GO:0033627) | 3.45428386 |
| 36 | long-term memory (GO:0007616) | 3.44455966 |
| 37 | peptide hormone processing (GO:0016486) | 3.38993784 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.36174161 |
| 39 | inositol phosphate-mediated signaling (GO:0048016) | 3.36021561 |
| 40 | positive regulation of gluconeogenesis (GO:0045722) | 3.30821367 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30754163 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.27187385 |
| 43 | dendritic spine morphogenesis (GO:0060997) | 3.27164905 |
| 44 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.23300516 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.21719715 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.20558114 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20295089 |
| 48 | long-term synaptic potentiation (GO:0060291) | 3.17679658 |
| 49 | vesicle transport along microtubule (GO:0047496) | 3.16131593 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.13940659 |
| 51 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.12397152 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12026880 |
| 53 | innervation (GO:0060384) | 3.09897452 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.07912758 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.07569168 |
| 56 | neuron recognition (GO:0008038) | 3.07494116 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06840476 |
| 58 | activation of protein kinase A activity (GO:0034199) | 3.06194516 |
| 59 | regulation of vesicle fusion (GO:0031338) | 3.06025255 |
| 60 | positive regulation of membrane potential (GO:0045838) | 3.05881332 |
| 61 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.01883902 |
| 62 | chemosensory behavior (GO:0007635) | 3.01539119 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.99362832 |
| 64 | membrane depolarization during action potential (GO:0086010) | 2.97171144 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 2.96369968 |
| 66 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.96133450 |
| 67 | insulin secretion (GO:0030073) | 2.94920598 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 2.94202739 |
| 69 | cell communication by electrical coupling (GO:0010644) | 2.92211619 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91432395 |
| 71 | dendrite morphogenesis (GO:0048813) | 2.89978343 |
| 72 | negative regulation of complement activation (GO:0045916) | 2.89618228 |
| 73 | * neurotransmitter transport (GO:0006836) | 2.89268343 |
| 74 | response to histamine (GO:0034776) | 2.86985684 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86554254 |
| 76 | behavioral fear response (GO:0001662) | 2.86462666 |
| 77 | behavioral defense response (GO:0002209) | 2.86462666 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86009533 |
| 79 | membrane depolarization (GO:0051899) | 2.85436026 |
| 80 | neuromuscular process controlling balance (GO:0050885) | 2.84859366 |
| 81 | cellular response to ethanol (GO:0071361) | 2.84623600 |
| 82 | lipid translocation (GO:0034204) | 2.84021937 |
| 83 | phospholipid translocation (GO:0045332) | 2.84021937 |
| 84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.83814537 |
| 85 | nerve growth factor signaling pathway (GO:0038180) | 2.83787881 |
| 86 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.83351173 |
| 87 | Golgi to endosome transport (GO:0006895) | 2.83300220 |
| 88 | macroautophagy (GO:0016236) | 2.81120325 |
| 89 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80746796 |
| 90 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79548122 |
| 91 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.79539003 |
| 92 | COPII vesicle coating (GO:0048208) | 2.78041249 |
| 93 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.77252447 |
| 94 | positive regulation of vesicle fusion (GO:0031340) | 2.76056871 |
| 95 | axonal fasciculation (GO:0007413) | 2.74722428 |
| 96 | sphingomyelin metabolic process (GO:0006684) | 2.73480976 |
| 97 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.72607554 |
| 98 | regulation of dendritic spine development (GO:0060998) | 2.72255287 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.71994280 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 2.70582611 |
| 101 | cellular response to vitamin D (GO:0071305) | 2.70221514 |
| 102 | clathrin coat assembly (GO:0048268) | 2.69956144 |
| 103 | establishment of nucleus localization (GO:0040023) | 2.69792773 |
| 104 | gamma-aminobutyric acid transport (GO:0015812) | 2.68873394 |
| 105 | fear response (GO:0042596) | 2.68593568 |
| 106 | regulation of execution phase of apoptosis (GO:1900117) | 2.67637065 |
| 107 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.66127334 |
| 108 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.66016481 |
| 109 | potassium ion import (GO:0010107) | 2.65344959 |
| 110 | cellular zinc ion homeostasis (GO:0006882) | 2.65058604 |
| 111 | membrane hyperpolarization (GO:0060081) | 2.64186942 |
| 112 | hemidesmosome assembly (GO:0031581) | 2.63590475 |
| 113 | response to pheromone (GO:0019236) | 2.63310405 |
| 114 | early endosome to late endosome transport (GO:0045022) | 2.63022624 |
| 115 | phospholipid dephosphorylation (GO:0046839) | 2.62595335 |
| 116 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.62314102 |
| 117 | positive regulation of Rap GTPase activity (GO:0032854) | 2.62126000 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 2.59538050 |
| 119 | positive regulation of fibroblast migration (GO:0010763) | 2.59100449 |
| 120 | dendritic spine organization (GO:0097061) | 2.59099269 |
| 121 | sphingosine metabolic process (GO:0006670) | 2.58786315 |
| 122 | actin filament depolymerization (GO:0030042) | 2.56475463 |
| 123 | positive regulation of synaptic transmission (GO:0050806) | 2.55148821 |
| 124 | negative regulation of cell killing (GO:0031342) | 2.55110351 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55110351 |
| 126 | organelle transport along microtubule (GO:0072384) | 2.54439306 |
| 127 | protein localization to endosome (GO:0036010) | 2.53857432 |
| 128 | long term synaptic depression (GO:0060292) | 2.53454662 |
| 129 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.53337096 |
| 130 | learning (GO:0007612) | 2.52332330 |
| 131 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.51950350 |
| 132 | synapse assembly (GO:0007416) | 2.51766016 |
| 133 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.51365678 |
| 134 | potassium ion homeostasis (GO:0055075) | 2.51337828 |
| 135 | auditory receptor cell differentiation (GO:0042491) | 2.51257941 |
| 136 | prepulse inhibition (GO:0060134) | 2.51062732 |
| 137 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.49997413 |
| 138 | endocytic recycling (GO:0032456) | 2.49623636 |
| 139 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.48866814 |
| 140 | negative regulation of protein activation cascade (GO:2000258) | 2.47420805 |
| 141 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.46336216 |
| 142 | myelin maintenance (GO:0043217) | 2.45441935 |
| 143 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.43178860 |
| 144 | smooth muscle tissue development (GO:0048745) | 2.42695063 |
| 145 | positive regulation of macroautophagy (GO:0016239) | 2.42149304 |
| 146 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.36961955 |
| 147 | negative regulation of hormone metabolic process (GO:0032351) | 2.32757236 |
| 148 | cellular response to vitamin (GO:0071295) | 2.32386917 |
| 149 | positive regulation of calcium ion import (GO:0090280) | 2.26953039 |
| 150 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.25890746 |
| 151 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.25721127 |
| 152 | regulation of transforming growth factor beta production (GO:0071634) | 2.25435577 |
| 153 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.24962008 |
| 154 | relaxation of cardiac muscle (GO:0055119) | 2.23569154 |
| 155 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.22783746 |
| 156 | import into cell (GO:0098657) | 2.22762687 |
| 157 | iron ion import (GO:0097286) | 2.22460696 |
| 158 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.21780862 |
| 159 | zinc ion homeostasis (GO:0055069) | 2.21368118 |
| 160 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.20456775 |
| 161 | regulation of Rap GTPase activity (GO:0032317) | 2.19446298 |
| 162 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.19064096 |
| 163 | regulation of extracellular matrix organization (GO:1903053) | 2.18713541 |
| 164 | skin morphogenesis (GO:0043589) | 2.14484986 |
| 165 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.13537606 |
| 166 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.13229710 |
| 167 | Rap protein signal transduction (GO:0032486) | 2.12263946 |
| 168 | negative regulation of humoral immune response (GO:0002921) | 2.08295379 |
| 169 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.08025077 |
| 170 | diol metabolic process (GO:0034311) | 2.07380384 |
| 171 | positive regulation of insulin secretion (GO:0032024) | 2.07308678 |
| 172 | negative regulation of fatty acid transport (GO:2000192) | 2.06447754 |
| 173 | response to parathyroid hormone (GO:0071107) | 2.06104705 |
| 174 | nodal signaling pathway (GO:0038092) | 2.05475112 |
| 175 | regulation of beta-amyloid formation (GO:1902003) | 2.05006788 |
| 176 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.03612666 |
| 177 | response to lead ion (GO:0010288) | 2.03390780 |
| 178 | mRNA modification (GO:0016556) | 2.02773133 |
| 179 | inositol metabolic process (GO:0006020) | 2.02154159 |
| 180 | extracellular regulation of signal transduction (GO:1900115) | 2.01595101 |
| 181 | extracellular negative regulation of signal transduction (GO:1900116) | 2.01595101 |
| 182 | glycerophospholipid catabolic process (GO:0046475) | 2.00826734 |
| 183 | glomerular visceral epithelial cell development (GO:0072015) | 2.00357407 |
| 184 | regulation of protein glycosylation (GO:0060049) | 1.97598733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.85478764 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.44554665 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54155613 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.63911557 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53096817 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43354069 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40766713 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37579121 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.23057516 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16416318 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15798246 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13326123 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13326123 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.09178497 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.03835011 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02486920 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02151280 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99851223 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.98156323 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95270820 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93973068 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89606265 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81201482 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79503670 |
| 25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78796742 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73969666 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72319439 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.70412423 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69503516 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68948503 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68503614 |
| 32 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68136097 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65134881 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63252242 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63095517 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62816873 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62451663 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61648240 |
| 39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61422770 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60697913 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57164067 |
| 42 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.56397211 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54893441 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54756262 |
| 45 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52251741 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52016982 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50555040 |
| 48 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49931076 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48974432 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48415638 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43921017 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43517797 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42758544 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41217300 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40081156 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39552380 |
| 57 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.38704988 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37100417 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37062040 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36701440 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.36369467 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35394798 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32884583 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32621854 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32362245 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31848757 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31266580 |
| 68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30687410 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29763292 |
| 70 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28473729 |
| 71 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28186585 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27377397 |
| 73 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27300117 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27079886 |
| 75 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25586622 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25121032 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23684888 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23597786 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.23073297 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22447918 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22428619 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20708937 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20227868 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19438324 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19160941 |
| 86 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18693709 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18323643 |
| 88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.17775871 |
| 89 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17669010 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17295225 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17242408 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16671149 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15861295 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15828176 |
| 95 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15749911 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15626451 |
| 97 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15213254 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14454776 |
| 99 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13075702 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12814485 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12701905 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12180090 |
| 103 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12035384 |
| 104 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12035384 |
| 105 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11049238 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10315953 |
| 107 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09965026 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09667191 |
| 109 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08559353 |
| 110 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08525714 |
| 111 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08060352 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07482619 |
| 113 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07424437 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06322524 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05682480 |
| 116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05206590 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04309780 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03600561 |
| 119 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03340118 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02769377 |
| 121 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02566091 |
| 122 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02125541 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01884145 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01875456 |
| 125 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00772581 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00756188 |
| 127 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00709399 |
| 128 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99690305 |
| 129 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98651712 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98213328 |
| 131 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98060648 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97815224 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97474218 |
| 134 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97452823 |
| 135 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97437889 |
| 136 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97397523 |
| 137 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97026914 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96899503 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96824578 |
| 140 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95889101 |
| 141 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95038550 |
| 142 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94731547 |
| 143 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93900681 |
| 144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93391422 |
| 145 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93059975 |
| 146 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92466290 |
| 147 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92094102 |
| 148 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92010227 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91458741 |
| 150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88835593 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88101033 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88101033 |
| 153 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88083372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.86458485 |
| 2 | MP0003880_abnormal_central_pattern | 4.22763469 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.82591926 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.64358584 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.18573757 |
| 6 | MP0004270_analgesia | 3.18192134 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.11608910 |
| 8 | MP0009745_abnormal_behavioral_response | 3.09311620 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.07877147 |
| 10 | MP0002064_seizures | 2.87858140 |
| 11 | MP0009046_muscle_twitch | 2.84153238 |
| 12 | MP0001958_emphysema | 2.77160440 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.62431336 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.60165927 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.57902378 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.56718088 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.53460858 |
| 18 | MP0002736_abnormal_nociception_after | 2.46770199 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.42402096 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.37154548 |
| 21 | MP0002272_abnormal_nervous_system | 2.28531125 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.17046884 |
| 23 | MP0006054_spinal_hemorrhage | 2.16339961 |
| 24 | MP0001486_abnormal_startle_reflex | 2.15285125 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.98306986 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.96900021 |
| 27 | MP0003787_abnormal_imprinting | 1.96782478 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.90856901 |
| 29 | MP0005275_abnormal_skin_tensile | 1.83670898 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.79667369 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.79173607 |
| 32 | MP0008569_lethality_at_weaning | 1.78072382 |
| 33 | MP0003279_aneurysm | 1.75021729 |
| 34 | MP0001348_abnormal_lacrimal_gland | 1.73901019 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.66760039 |
| 36 | MP0001970_abnormal_pain_threshold | 1.60728270 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.59804013 |
| 38 | MP0002822_catalepsy | 1.58959019 |
| 39 | MP0001944_abnormal_pancreas_morphology | 1.58287073 |
| 40 | MP0002184_abnormal_innervation | 1.56453945 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.52776743 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.52030134 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.51881331 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.50328677 |
| 45 | MP0002557_abnormal_social/conspecific_i | 1.49282753 |
| 46 | MP0003252_abnormal_bile_duct | 1.45044738 |
| 47 | MP0004858_abnormal_nervous_system | 1.44084338 |
| 48 | MP0001188_hyperpigmentation | 1.43317011 |
| 49 | MP0004510_myositis | 1.42805856 |
| 50 | MP0002163_abnormal_gland_morphology | 1.42516155 |
| 51 | MP0002168_other_aberrant_phenotype | 1.40275742 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.39545230 |
| 53 | MP0004272_abnormal_basement_membrane | 1.39124620 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.38530755 |
| 55 | MP0000778_abnormal_nervous_system | 1.36716734 |
| 56 | MP0001756_abnormal_urination | 1.36088940 |
| 57 | MP0000955_abnormal_spinal_cord | 1.35973252 |
| 58 | MP0003879_abnormal_hair_cell | 1.33654502 |
| 59 | MP0003195_calcinosis | 1.32979202 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.31683694 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.29740542 |
| 62 | MP0002006_tumorigenesis | 1.27755984 |
| 63 | * MP0005386_behavior/neurological_phenoty | 1.27440075 |
| 64 | * MP0004924_abnormal_behavior | 1.27440075 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.26714868 |
| 66 | MP0001984_abnormal_olfaction | 1.25481095 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.23386542 |
| 68 | MP0003633_abnormal_nervous_system | 1.21883384 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.19176194 |
| 70 | MP0010678_abnormal_skin_adnexa | 1.16486650 |
| 71 | MP0004885_abnormal_endolymph | 1.16179967 |
| 72 | MP0001299_abnormal_eye_distance/ | 1.15519867 |
| 73 | MP0003045_fibrosis | 1.14962623 |
| 74 | MP0002060_abnormal_skin_morphology | 1.14353738 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.13329371 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.12215005 |
| 77 | MP0000685_abnormal_immune_system | 1.10741120 |
| 78 | MP0010386_abnormal_urinary_bladder | 1.10740331 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 1.09745869 |
| 80 | MP0002254_reproductive_system_inflammat | 1.09270393 |
| 81 | MP0000604_amyloidosis | 1.08501269 |
| 82 | MP0008877_abnormal_DNA_methylation | 1.08267760 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 1.04069692 |
| 84 | MP0003690_abnormal_glial_cell | 1.01515060 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.98419483 |
| 86 | MP0005023_abnormal_wound_healing | 0.97513137 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.97341884 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.96431652 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.95937743 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.95828704 |
| 91 | MP0000516_abnormal_urinary_system | 0.95808900 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.95808900 |
| 93 | MP0004134_abnormal_chest_morphology | 0.95000332 |
| 94 | MP0004484_altered_response_of | 0.93061826 |
| 95 | MP0003631_nervous_system_phenotype | 0.93018472 |
| 96 | MP0001177_atelectasis | 0.91864082 |
| 97 | MP0005166_decreased_susceptibility_to | 0.91410035 |
| 98 | MP0002090_abnormal_vision | 0.90647361 |
| 99 | MP0003868_abnormal_feces_composition | 0.89888229 |
| 100 | MP0000920_abnormal_myelination | 0.88933745 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.88372606 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.86901750 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.86317063 |
| 104 | MP0004742_abnormal_vestibular_system | 0.85527049 |
| 105 | MP0002152_abnormal_brain_morphology | 0.85020835 |
| 106 | MP0005332_abnormal_amino_acid | 0.84989405 |
| 107 | MP0003329_amyloid_beta_deposits | 0.84855013 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.84840491 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.84614837 |
| 110 | MP0006082_CNS_inflammation | 0.84568725 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.83998679 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.83432385 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.83345025 |
| 114 | MP0006276_abnormal_autonomic_nervous | 0.81910245 |
| 115 | MP0001851_eye_inflammation | 0.81238752 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.79761389 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.79090711 |
| 118 | MP0003091_abnormal_cell_migration | 0.78660234 |
| 119 | MP0002229_neurodegeneration | 0.78497011 |
| 120 | MP0003075_altered_response_to | 0.78108056 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.78078608 |
| 122 | MP0005165_increased_susceptibility_to | 0.77914236 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.77748041 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.76677832 |
| 125 | MP0004808_abnormal_hematopoietic_stem | 0.76207385 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.75519941 |
| 127 | MP0001790_abnormal_immune_system | 0.73836316 |
| 128 | MP0005387_immune_system_phenotype | 0.73836316 |
| 129 | MP0000427_abnormal_hair_cycle | 0.73621083 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.73510198 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.73022323 |
| 132 | MP0008874_decreased_physiological_sensi | 0.72667899 |
| 133 | MP0003303_peritoneal_inflammation | 0.72382341 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.71919304 |
| 135 | MP0003122_maternal_imprinting | 0.71865045 |
| 136 | MP0005409_darkened_coat_color | 0.70978770 |
| 137 | MP0001243_abnormal_dermal_layer | 0.70840248 |
| 138 | MP0000015_abnormal_ear_pigmentation | 0.70056032 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.69270389 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.68886744 |
| 141 | MP0005310_abnormal_salivary_gland | 0.68591407 |
| 142 | MP0004085_abnormal_heartbeat | 0.68121839 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.68070755 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.67723376 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.67417291 |
| 146 | MP0005535_abnormal_body_temperature | 0.67302906 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.67184632 |
| 148 | MP0002009_preneoplasia | 0.66172575 |
| 149 | MP0005253_abnormal_eye_physiology | 0.65599444 |
| 150 | MP0003634_abnormal_glial_cell | 0.63007111 |
| 151 | MP0000751_myopathy | 0.62207231 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.61515625 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.61161299 |
| 154 | MP0004215_abnormal_myocardial_fiber | 0.60216539 |
| 155 | MP0005174_abnormal_tail_pigmentation | 0.59391018 |
| 156 | MP0001963_abnormal_hearing_physiology | 0.59028415 |
| 157 | MP0001765_abnormal_ion_homeostasis | 0.58564815 |
| 158 | MP0002752_abnormal_somatic_nervous | 0.53886914 |
| 159 | MP0005171_absent_coat_pigmentation | 0.52844051 |
| 160 | MP0003632_abnormal_nervous_system | 0.52647866 |
| 161 | MP0003283_abnormal_digestive_organ | 0.52110673 |
| 162 | MP0004043_abnormal_pH_regulation | 0.50944543 |
| 163 | MP0002896_abnormal_bone_mineralization | 0.50937540 |
| 164 | MP0008872_abnormal_physiological_respon | 0.50310102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.95915611 |
| 2 | Focal seizures (HP:0007359) | 4.78614057 |
| 3 | Febrile seizures (HP:0002373) | 4.58242383 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.45614942 |
| 5 | Myokymia (HP:0002411) | 4.16740193 |
| 6 | Visual hallucinations (HP:0002367) | 4.10276326 |
| 7 | Increased CSF protein (HP:0002922) | 3.89754334 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.83243640 |
| 9 | Atonic seizures (HP:0010819) | 3.64374040 |
| 10 | Absence seizures (HP:0002121) | 3.60927514 |
| 11 | Hyperphosphatemia (HP:0002905) | 3.47142413 |
| 12 | Cardiovascular calcification (HP:0011915) | 3.44685993 |
| 13 | Broad-based gait (HP:0002136) | 3.32083288 |
| 14 | Action tremor (HP:0002345) | 3.23200892 |
| 15 | Dialeptic seizures (HP:0011146) | 3.20404852 |
| 16 | Premature rupture of membranes (HP:0001788) | 3.18707387 |
| 17 | Papilledema (HP:0001085) | 3.10124251 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.07516217 |
| 19 | Vascular calcification (HP:0004934) | 3.05498201 |
| 20 | Poor eye contact (HP:0000817) | 3.04247023 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 2.96445104 |
| 22 | Truncal ataxia (HP:0002078) | 2.92729477 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.91227971 |
| 24 | Mucopolysacchariduria (HP:0008155) | 2.91227971 |
| 25 | Genetic anticipation (HP:0003743) | 2.87044326 |
| 26 | Mitral stenosis (HP:0001718) | 2.84390022 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83194105 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83194105 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83194105 |
| 30 | Hematochezia (HP:0002573) | 2.79718805 |
| 31 | Drooling (HP:0002307) | 2.77403336 |
| 32 | Excessive salivation (HP:0003781) | 2.77403336 |
| 33 | Impaired smooth pursuit (HP:0007772) | 2.74088289 |
| 34 | Impaired social interactions (HP:0000735) | 2.70232176 |
| 35 | Abnormal social behavior (HP:0012433) | 2.70232176 |
| 36 | Atrophic scars (HP:0001075) | 2.69297559 |
| 37 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.66837140 |
| 38 | Increased circulating renin level (HP:0000848) | 2.66622935 |
| 39 | Hypoventilation (HP:0002791) | 2.57897793 |
| 40 | Amblyopia (HP:0000646) | 2.56038991 |
| 41 | Dysmetric saccades (HP:0000641) | 2.54179588 |
| 42 | Aortic dissection (HP:0002647) | 2.52227948 |
| 43 | Inappropriate behavior (HP:0000719) | 2.51681218 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.50847412 |
| 45 | Macroorchidism (HP:0000053) | 2.48013425 |
| 46 | Congenital stationary night blindness (HP:0007642) | 2.45852930 |
| 47 | Aqueductal stenosis (HP:0002410) | 2.42872663 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.40278146 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.39637550 |
| 50 | Postural instability (HP:0002172) | 2.39306358 |
| 51 | Hyperglycemia (HP:0003074) | 2.39053075 |
| 52 | Depression (HP:0000716) | 2.37963075 |
| 53 | Aortic aneurysm (HP:0004942) | 2.37363800 |
| 54 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.35965796 |
| 55 | Shoulder girdle muscle weakness (HP:0003547) | 2.35600652 |
| 56 | Absent frontal sinuses (HP:0002688) | 2.35062900 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.31493056 |
| 58 | Orthostatic hypotension (HP:0001278) | 2.26762981 |
| 59 | Protruding tongue (HP:0010808) | 2.26341232 |
| 60 | Urethral obstruction (HP:0000796) | 2.25887420 |
| 61 | Stereotypic behavior (HP:0000733) | 2.25542024 |
| 62 | Dysmetria (HP:0001310) | 2.24553232 |
| 63 | Glucose intolerance (HP:0000833) | 2.23959418 |
| 64 | Diplopia (HP:0000651) | 2.23767872 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.23767872 |
| 66 | Mutism (HP:0002300) | 2.23104804 |
| 67 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.22833953 |
| 68 | Pelvic girdle muscle weakness (HP:0003749) | 2.20365350 |
| 69 | Absent speech (HP:0001344) | 2.18198608 |
| 70 | Protrusio acetabuli (HP:0003179) | 2.17995102 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.16350445 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15428919 |
| 73 | Metabolic alkalosis (HP:0200114) | 2.15176073 |
| 74 | Tetraparesis (HP:0002273) | 2.15155177 |
| 75 | Scanning speech (HP:0002168) | 2.14518486 |
| 76 | Hyperventilation (HP:0002883) | 2.14065059 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.14062530 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14062530 |
| 79 | Striae distensae (HP:0001065) | 2.12307296 |
| 80 | Postural tremor (HP:0002174) | 2.12019783 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.11954536 |
| 82 | Abnormal glucose tolerance (HP:0001952) | 2.10578717 |
| 83 | Hemiplegia (HP:0002301) | 2.10050706 |
| 84 | Episodic fever (HP:0001954) | 2.09469102 |
| 85 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08613711 |
| 86 | Neurofibrillary tangles (HP:0002185) | 2.07903315 |
| 87 | Spondylolisthesis (HP:0003302) | 2.06801355 |
| 88 | Widely spaced teeth (HP:0000687) | 2.05972473 |
| 89 | Thoracolumbar scoliosis (HP:0002944) | 2.05347207 |
| 90 | Thin bony cortex (HP:0002753) | 2.02563520 |
| 91 | Enlarged penis (HP:0000040) | 2.01832375 |
| 92 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.01670550 |
| 93 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.01670550 |
| 94 | Malnutrition (HP:0004395) | 2.01237090 |
| 95 | Urinary urgency (HP:0000012) | 2.01216793 |
| 96 | Testicular neoplasm (HP:0010788) | 1.99501441 |
| 97 | Lower limb asymmetry (HP:0100559) | 1.97947669 |
| 98 | Chronic diarrhea (HP:0002028) | 1.97840034 |
| 99 | Hypokalemic alkalosis (HP:0001949) | 1.97402909 |
| 100 | Overgrowth (HP:0001548) | 1.97130043 |
| 101 | Abnormality of salivation (HP:0100755) | 1.95970054 |
| 102 | Frequent falls (HP:0002359) | 1.95062103 |
| 103 | Tetany (HP:0001281) | 1.95010088 |
| 104 | Hypoalbuminemia (HP:0003073) | 1.94870208 |
| 105 | Abnormal albumin level (HP:0012116) | 1.94870208 |
| 106 | Pointed chin (HP:0000307) | 1.94771170 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 1.94723466 |
| 108 | Metaphyseal dysplasia (HP:0100255) | 1.94487903 |
| 109 | Hamartoma of the eye (HP:0010568) | 1.94033801 |
| 110 | Abnormality of vitamin B metabolism (HP:0004340) | 1.93873238 |
| 111 | Exotropia (HP:0000577) | 1.91414863 |
| 112 | Central scotoma (HP:0000603) | 1.90679508 |
| 113 | Menstrual irregularities (HP:0000858) | 1.90323300 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.90026783 |
| 115 | Intellectual disability, profound (HP:0002187) | 1.89537562 |
| 116 | Short chin (HP:0000331) | 1.89422274 |
| 117 | Cerebral aneurysm (HP:0004944) | 1.88982497 |
| 118 | Anxiety (HP:0000739) | 1.88411353 |
| 119 | Blue irides (HP:0000635) | 1.87940488 |
| 120 | Hemiparesis (HP:0001269) | 1.87883664 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.86670620 |
| 122 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85013605 |
| 123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85013605 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85013605 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.84729887 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.84729887 |
| 127 | Hypoplasia of dental enamel (HP:0006297) | 1.81359038 |
| 128 | Bradykinesia (HP:0002067) | 1.80795434 |
| 129 | Ankle clonus (HP:0011448) | 1.80785282 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.80771384 |
| 131 | Abnormal eating behavior (HP:0100738) | 1.80706048 |
| 132 | Type II lissencephaly (HP:0007260) | 1.79906571 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.79570114 |
| 134 | Abnormality of macular pigmentation (HP:0008002) | 1.79293615 |
| 135 | Epileptiform EEG discharges (HP:0011182) | 1.79251339 |
| 136 | Cardiomegaly (HP:0001640) | 1.79213918 |
| 137 | Open mouth (HP:0000194) | 1.79130266 |
| 138 | Albinism (HP:0001022) | 1.78841533 |
| 139 | Resting tremor (HP:0002322) | 1.78489883 |
| 140 | Ankyloglossia (HP:0010296) | 1.74951948 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 1.73549427 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.73540444 |
| 143 | Fragile skin (HP:0001030) | 1.73421551 |
| 144 | Cubitus valgus (HP:0002967) | 1.73337975 |
| 145 | Sensory axonal neuropathy (HP:0003390) | 1.72382607 |
| 146 | Obstructive sleep apnea (HP:0002870) | 1.72225591 |
| 147 | Persistence of primary teeth (HP:0006335) | 1.71703712 |
| 148 | Generalized hypopigmentation of hair (HP:0011358) | 1.70137734 |
| 149 | Obsessive-compulsive behavior (HP:0000722) | 1.70041777 |
| 150 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69279230 |
| 151 | Agitation (HP:0000713) | 1.68905365 |
| 152 | EEG with generalized epileptiform discharges (HP:0011198) | 1.67477991 |
| 153 | Double outlet right ventricle (HP:0001719) | 1.67056628 |
| 154 | Congenital malformation of the right heart (HP:0011723) | 1.67056628 |
| 155 | Hyperextensible skin (HP:0000974) | 1.66854028 |
| 156 | Follicular hyperkeratosis (HP:0007502) | 1.66810309 |
| 157 | Wormian bones (HP:0002645) | 1.65272889 |
| 158 | Mitral valve prolapse (HP:0001634) | 1.65114419 |
| 159 | Progressive inability to walk (HP:0002505) | 1.64616804 |
| 160 | Tetraplegia (HP:0002445) | 1.63155662 |
| 161 | Arterial tortuosity (HP:0005116) | 1.62858400 |
| 162 | Intention tremor (HP:0002080) | 1.62738441 |
| 163 | Vacuolated lymphocytes (HP:0001922) | 1.60662783 |
| 164 | Deeply set eye (HP:0000490) | 1.60374410 |
| 165 | Termporal pattern (HP:0011008) | 1.60286080 |
| 166 | Insidious onset (HP:0003587) | 1.60286080 |
| 167 | Limb-girdle muscle atrophy (HP:0003797) | 1.60184701 |
| 168 | Relative macrocephaly (HP:0004482) | 1.60177980 |
| 169 | Cheilitis (HP:0100825) | 1.59129472 |
| 170 | Hypothermia (HP:0002045) | 1.58712650 |
| 171 | Focal segmental glomerulosclerosis (HP:0000097) | 1.57964119 |
| 172 | Hyperaldosteronism (HP:0000859) | 1.57491649 |
| 173 | Abnormality of the lower motor neuron (HP:0002366) | 1.54761178 |
| 174 | Megalencephaly (HP:0001355) | 1.54336061 |
| 175 | Bundle branch block (HP:0011710) | 1.54054069 |
| 176 | Abnormality of oral frenula (HP:0000190) | 1.53662421 |
| 177 | Deep palmar crease (HP:0006191) | 1.51857424 |
| 178 | Ventricular fibrillation (HP:0001663) | 1.51843747 |
| 179 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.51038511 |
| 180 | Vascular tortuosity (HP:0004948) | 1.50186395 |
| 181 | Abnormal EKG (HP:0003115) | 1.49921264 |
| 182 | Impaired vibratory sensation (HP:0002495) | 1.49414927 |
| 183 | Macroglossia (HP:0000158) | 1.48529794 |
| 184 | Spinal canal stenosis (HP:0003416) | 1.48433530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.72825108 |
| 2 | EPHA4 | 3.84065461 |
| 3 | MAP3K9 | 3.42633732 |
| 4 | RIPK4 | 2.90427597 |
| 5 | MAP3K4 | 2.88216486 |
| 6 | DAPK2 | 2.35821658 |
| 7 | TRPM7 | 2.30368410 |
| 8 | MINK1 | 2.27364804 |
| 9 | MAP2K7 | 2.14656473 |
| 10 | PAK6 | 2.13603877 |
| 11 | CAMKK1 | 2.13146673 |
| 12 | MARK1 | 2.03985943 |
| 13 | CAMKK2 | 1.90333636 |
| 14 | KSR2 | 1.87897127 |
| 15 | PRKD3 | 1.84482708 |
| 16 | AKT3 | 1.80758945 |
| 17 | MAP3K13 | 1.79505904 |
| 18 | STK24 | 1.77407325 |
| 19 | SIK2 | 1.73619895 |
| 20 | MAP3K2 | 1.70342360 |
| 21 | NTRK2 | 1.67364476 |
| 22 | STK38 | 1.59480395 |
| 23 | PLK2 | 1.59249407 |
| 24 | MAP3K14 | 1.56643832 |
| 25 | FGFR4 | 1.56541518 |
| 26 | NEK9 | 1.54492043 |
| 27 | FRK | 1.54216732 |
| 28 | KSR1 | 1.53738239 |
| 29 | MAP2K4 | 1.50780067 |
| 30 | MYLK | 1.45536568 |
| 31 | NLK | 1.44707491 |
| 32 | CDK5 | 1.44168221 |
| 33 | MAP3K12 | 1.38892839 |
| 34 | NTRK1 | 1.37839293 |
| 35 | DAPK1 | 1.35649138 |
| 36 | FES | 1.34297061 |
| 37 | MST4 | 1.31186738 |
| 38 | CAMK1G | 1.30466150 |
| 39 | PHKG2 | 1.21889414 |
| 40 | PHKG1 | 1.21889414 |
| 41 | SGK2 | 1.20155662 |
| 42 | SGK3 | 1.18385263 |
| 43 | ALK | 1.17849552 |
| 44 | SGK1 | 1.15918578 |
| 45 | MAP2K6 | 1.15830611 |
| 46 | PRKCH | 1.15117776 |
| 47 | STK3 | 1.11943572 |
| 48 | RET | 1.11265785 |
| 49 | RIPK1 | 1.08056246 |
| 50 | PRPF4B | 1.05921229 |
| 51 | SCYL2 | 1.05190479 |
| 52 | PTK2 | 1.04606601 |
| 53 | TNIK | 1.01311181 |
| 54 | LATS2 | 0.99713984 |
| 55 | STK11 | 0.99677413 |
| 56 | CAMK1 | 0.98368895 |
| 57 | MST1R | 0.98237741 |
| 58 | WNK1 | 0.97701570 |
| 59 | PRKG2 | 0.97650992 |
| 60 | GRK5 | 0.96777770 |
| 61 | PTK2B | 0.95719744 |
| 62 | TTN | 0.92943214 |
| 63 | BMPR2 | 0.91408293 |
| 64 | DMPK | 0.91106821 |
| 65 | SGK494 | 0.89272746 |
| 66 | SGK223 | 0.89272746 |
| 67 | CAMK1D | 0.87311454 |
| 68 | FER | 0.85894974 |
| 69 | WNK3 | 0.85327131 |
| 70 | TYRO3 | 0.84007521 |
| 71 | MAP3K7 | 0.83835367 |
| 72 | MAPK13 | 0.83254230 |
| 73 | PAK3 | 0.83037089 |
| 74 | EIF2AK3 | 0.82499777 |
| 75 | ERBB3 | 0.82451988 |
| 76 | PRKCG | 0.82321018 |
| 77 | PDK1 | 0.82150382 |
| 78 | STK38L | 0.81416725 |
| 79 | CAMK2A | 0.79739691 |
| 80 | TAOK1 | 0.79164931 |
| 81 | TYK2 | 0.77776633 |
| 82 | MAPK11 | 0.75471203 |
| 83 | CASK | 0.73065093 |
| 84 | PRKD2 | 0.71899779 |
| 85 | DYRK1A | 0.71501861 |
| 86 | STK39 | 0.71109367 |
| 87 | MAP3K1 | 0.69178713 |
| 88 | YES1 | 0.68759095 |
| 89 | MET | 0.68713815 |
| 90 | DDR2 | 0.68576145 |
| 91 | JAK1 | 0.66340713 |
| 92 | RAF1 | 0.66256449 |
| 93 | MAPK7 | 0.65958955 |
| 94 | PINK1 | 0.65663223 |
| 95 | UHMK1 | 0.65425041 |
| 96 | PNCK | 0.65203516 |
| 97 | FGFR3 | 0.63317648 |
| 98 | ACVR1B | 0.62855072 |
| 99 | ITK | 0.62506857 |
| 100 | TNK2 | 0.62503040 |
| 101 | PDGFRA | 0.61719236 |
| 102 | PAK2 | 0.61653802 |
| 103 | JAK3 | 0.60776808 |
| 104 | MAP3K3 | 0.58671457 |
| 105 | TEC | 0.58069789 |
| 106 | ARAF | 0.57631929 |
| 107 | GRK1 | 0.57446919 |
| 108 | MARK2 | 0.57414654 |
| 109 | RPS6KA3 | 0.57233830 |
| 110 | PDGFRB | 0.55706396 |
| 111 | ROCK2 | 0.55522541 |
| 112 | CDC42BPA | 0.55397201 |
| 113 | EPHB1 | 0.55293465 |
| 114 | FGFR2 | 0.54396119 |
| 115 | MAPK10 | 0.54045716 |
| 116 | PDPK1 | 0.53853177 |
| 117 | IRAK3 | 0.53421828 |
| 118 | GSK3A | 0.52814998 |
| 119 | CDK18 | 0.52600390 |
| 120 | CAMK4 | 0.52153644 |
| 121 | CAMK2B | 0.52069873 |
| 122 | FYN | 0.51727911 |
| 123 | CDK15 | 0.51668812 |
| 124 | LATS1 | 0.51113629 |
| 125 | MAPK12 | 0.50475172 |
| 126 | MOS | 0.50310042 |
| 127 | CDK14 | 0.49301613 |
| 128 | MAP3K6 | 0.48819160 |
| 129 | PRKCB | 0.47557997 |
| 130 | MAP2K1 | 0.47386161 |
| 131 | PRKCE | 0.47074691 |
| 132 | PIK3CG | 0.44808466 |
| 133 | EPHA3 | 0.44528589 |
| 134 | ZAP70 | 0.44413855 |
| 135 | LMTK2 | 0.42674212 |
| 136 | OXSR1 | 0.42457820 |
| 137 | HIPK2 | 0.42434140 |
| 138 | KIT | 0.42376657 |
| 139 | CDK12 | 0.40484834 |
| 140 | CDK11A | 0.40346434 |
| 141 | NEK6 | 0.39061925 |
| 142 | MAPK8 | 0.38992744 |
| 143 | FGR | 0.37934097 |
| 144 | CAMK2D | 0.36355573 |
| 145 | HCK | 0.36314183 |
| 146 | SIK3 | 0.36012303 |
| 147 | CSNK1G2 | 0.33055211 |
| 148 | PRKCZ | 0.33010408 |
| 149 | SRC | 0.32039677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.98049903 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.50372360 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.38954823 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.32438861 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.18438628 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.14099056 |
| 7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.13746160 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06937132 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.02270459 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.96822728 |
| 11 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.93588377 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93190996 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.88699050 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77803919 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.71812766 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71771500 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.68527564 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64888951 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62654367 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.61312390 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.58110269 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56794233 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56782911 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47506693 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43003636 |
| 26 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.39321157 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37949736 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37246257 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.34262983 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33408889 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.32147584 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30995332 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29626444 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29297649 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.24567019 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21068942 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20806995 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20578648 |
| 39 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.16348634 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12118767 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11171043 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11127780 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09220297 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.09052792 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08776831 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.08699131 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07182443 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95701232 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.95174203 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94196371 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93893562 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91263801 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90917749 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89989471 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.88039063 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87289240 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.87021681 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86619566 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.85769637 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85062838 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84708802 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84582026 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84513335 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84378480 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84368117 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83868425 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83757510 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83702007 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83659889 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83513607 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82737872 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80697673 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79465517 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.76357401 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76142672 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73815604 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72481471 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70443105 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70231392 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69218304 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68021890 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67923537 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66897710 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66798878 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65075483 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64989096 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64661768 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64122046 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63944145 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63706183 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63672685 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63271876 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63178977 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61998004 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61218544 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.61133966 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60310728 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60229836 |
| 99 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59644046 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59317589 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57516107 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55571953 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55552356 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.54839627 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54783746 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54725516 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.54688229 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54142945 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53958382 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53587312 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.53138540 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52931994 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51604442 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51522423 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50371598 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.50045116 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49684058 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49554311 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.49410866 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.49370712 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49164434 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49155326 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48661135 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.48613889 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.48308619 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.48272744 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.48244683 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47766364 |

